Veteran fund manager Neil Woodford has put more money behind stem cell therapies by increasing his stake in ReNeuron. His firm, Woodford Investment Management, has bought 26,200,000 more shares in the Aim-listed biotech, bringing its stake up to 356,700,000 shares.
http://ift.tt/1qo9BLz
http://ift.tt/1qo9BLz
No comments:
Post a Comment